MedPath

ALLERGAN MEDICAL

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

12

Active:0
Completed:11

Trial Phases

2 Phases

Phase 4:2
Not Applicable:7

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Not Applicable
7 (77.8%)
Phase 4
2 (22.2%)

Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips

Completed
Conditions
Lip Augmentation
First Posted Date
2012-06-27
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
62
Registration Number
NCT01629134

Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement

Not Applicable
Completed
Conditions
Lip Volume Enhancement
First Posted Date
2012-04-17
Last Posted Date
2019-01-17
Lead Sponsor
Allergan Medical
Target Recruit Count
285
Registration Number
NCT01579305

The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face

Completed
Conditions
Age-related Volume Deficit in the Mid-face
First Posted Date
2012-03-21
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
115
Registration Number
NCT01559064

Safety and Effectiveness of Juvéderm® Ultra Lip Injectable Gel for Lip Enhancement

Not Applicable
Completed
Conditions
Lip Enhancement
First Posted Date
2010-08-06
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
62
Registration Number
NCT01176773

European Union (EU) Post-Market Study on Easyband®

Completed
Conditions
Morbid Obesity
First Posted Date
2009-07-29
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
112
Registration Number
NCT00948246
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.